Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Earl HM, Hiller L, Vallier AL, Loi S, McAdam K, Hughes-Davies L, Harnett AN, Ah-See ML, Simcock R, Rea D, Raj S, Woodings P, Harries M, Howe D, Raynes K, Higgins HB, Wilcox M, Plummer C, Mansi J, Gounaris I, Mahler-Araujo B, Provenzano E, Chhabra A, Abraham JE, Caldas C, Hall PS, McCabe C, Hulme C, Miles D, Wardley AM, Cameron DA, Dunn JA; PERSEPHONE Steering Committee and Trial Investigators. Earl HM, et al. Among authors: harries m. Lancet. 2019 Jun 29;393(10191):2599-2612. doi: 10.1016/S0140-6736(19)30650-6. Epub 2019 Jun 6. Lancet. 2019. PMID: 31178152 Free PMC article. Clinical Trial.
Advanced Triple-Negative Breast Cancer.
Patel G, Prince A, Harries M. Patel G, et al. Among authors: harries m. Semin Oncol Nurs. 2024 Feb;40(1):151548. doi: 10.1016/j.soncn.2023.151548. Epub 2023 Nov 25. Semin Oncol Nurs. 2024. PMID: 38008654 Review.
Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma.
Bolte LA, Lee KA, Björk JR, Leeming ER, Campmans-Kuijpers MJE, de Haan JJ, Vila AV, Maltez-Thomas A, Segata N, Board R, Harries M, Lorigan P, de Vries EGE, Nathan P, Fehrmann R, Bataille V, Spector TD, Hospers GAP, Weersma RK. Bolte LA, et al. Among authors: harries m. JAMA Oncol. 2023 May 1;9(5):705-709. doi: 10.1001/jamaoncol.2022.7753. JAMA Oncol. 2023. PMID: 36795408 Free PMC article.
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma.
Björk JR, Bolte LA, Maltez Thomas A, Lee KA, Rossi N, Wind TT, Smit LM, Armanini F, Asnicar F, Blanco-Miguez A, Board R, Calbet-Llopart N, Derosa L, Dhomen N, Brooks K, Harland M, Harries M, Lorigan P, Manghi P, Marais R, Newton-Bishop J, Nezi L, Pinto F, Potrony M, Puig S, Serra-Bellver P, Shaw HM, Tamburini S, Valpione S, Waldron L, Zitvogel L, Zolfo M, de Vries EGE, Nathan P, Fehrmann RSN, Spector TD, Bataille V, Segata N, Hospers GAP, Weersma RK. Björk JR, et al. Among authors: harries m. Nat Med. 2024 Mar;30(3):785-796. doi: 10.1038/s41591-024-02803-3. Epub 2024 Feb 16. Nat Med. 2024. PMID: 38365950 Free PMC article.
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma.
Visconti A, Rossi N, Deriš H, Lee KA, Hanić M, Trbojević-Akmačić I, Thomas AM, Bolte LA, Björk JR, Hooiveld-Noeken JS, Board R, Harland M, Newton-Bishop J, Harries M, Sacco JJ, Lorigan P, Shaw HM, de Vries EGE, Fehrmann RSN, Weersma RK, Spector TD, Nathan P, Hospers GAP, Sasieni P, Bataille V, Lauc G, Falchi M. Visconti A, et al. Among authors: harries m. BMC Cancer. 2023 Feb 18;23(1):166. doi: 10.1186/s12885-023-10511-3. BMC Cancer. 2023. PMID: 36805683 Free PMC article.
Frontal Fibrosing Alopecia: An Update.
Messenger AG, Asfour L, Harries M. Messenger AG, et al. Among authors: harries m. Am J Clin Dermatol. 2024 Dec 19. doi: 10.1007/s40257-024-00912-w. Online ahead of print. Am J Clin Dermatol. 2024. PMID: 39699852 Review.
School-Based Health Care: An Overview.
Harries M. Harries M. Pediatr Ann. 2024 Dec;53(12):e435-e437. doi: 10.3928/19382359-20241023-01. Epub 2024 Dec 1. Pediatr Ann. 2024. PMID: 39653338 Review.
British Association of Dermatologists living guideline for managing people with alopecia areata 2024.
Harries MJ, Ascott A, Asfour L, Farrant P, Hale G, Holmes S, Johnson A, Jolliffe VML, Kazmi A, Macbeth AE, Messenger AG, Noor A, Takwale A, Thompson AR, Hashme M, Manounah L, Mohd Mustapa MF, Constantin AM; British Association of Dermatologists’ Clinical Standards Unit. Harries MJ, et al. Br J Dermatol. 2024 Oct 21:ljae385. doi: 10.1093/bjd/ljae385. Online ahead of print. Br J Dermatol. 2024. PMID: 39432739 No abstract available.
410 results